- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02664285
Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized prospective comparative clinical study will be conducted in Ain Shams University, Maternity Hospital.
This study will include a sample of (136) pregnant women with gestational diabetes mellitus and type 2 diabetes mellitus who underwent elective Cesarean section.
Patients will b divided into two groups:
Group A (closure group): will include 68 pregnant women who underwent elective Cesarean section with closure of subcutaneous tissue. Group B (non closure group): will include 68 pregnant women who underwent elective Cesarean section without closure of subcutaneous tissue.
• All participants in the study will have consent.
All included women will be subjected to the following:
- History Full history taking, (personal, present, past and obstetrics history).
- Clinical examination including:
General examination:
- Assessment of vital data
- Assessment of general condition.
- Cardiac and chest examination, to exclude any contraindication for anesthesia.
Abdominal examination:
Assessment of fundal level for fetal dating, fetal lie and fetal heart sound. 3. Investigations: Laboratory Complete blood picture.- Random blood sugar.
Ultrasonography:
Fetal biometry for fetal dating and fetal viability. 4. All participants operated under general or spinal anesthesia. Prophylactic antibiotic is given according to the approved protocol of Ain Shams Maternity Hospital (as two intravenous doses of broad spectrum penicillin (after clamping of the umbilical cord and 12 hours postoperatively. Oral antibiotic of the same group was then started for 3-5 days.
5.In group A (closure group)the subcutaneous fat will be closed with three to five interrupted sutures. The sutures were tied until the tissue was adequately re-approximated, but not as hard as possible to avoid necrosis. In group B (non closure group) the subcutaneous fat will not sutured.
6.In all participants Skin to be closed by subcuticular stitches using absorbable polyglactin 910 suture 7. Dressing is removed after 48hours postoperatively, to be disinfected with alcohol 70% antiseptic solution daily in both groups.
8. The wound is to be inspected 48 hours, 7 days and one month after the cesarean section.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women in childbearing period (18-45 years).
- Women planned for elective cesarean section.
- Pregnant women with gestational diabetes according to medical records.
Exclusion Criteria:
- Hemoglobin less than 10g/dl.
- Intra operative events that may themselves predispose to postoperative infection (e.g. operative time more than 90 minutes).
- Rupture of membrane more than 12 hours.
- Receive corticosteroid medications.
- Immunosuppressive disease or Auto immune disease.
- Concurrent infection (e.g. signs of pyelonephritis, chest infection).
- Previous history of two C.S.
- Previous laparotomy other than C.S.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: closure of subcutaneous tissue
in diabetic patients, the subcutaneous fat will be closed with three to five interrupted sutures.
The sutures were tied until the tissue was adequately re-approximated, but not as hard as possible to avoid necrosis after cesarean section.
|
the subcutaneous fat will be closed with three to five interrupted sutures.
The sutures were tied until the tissue was adequately re-approximated, but not as hard as possible to avoid necrosis after cesarean section in diabetic patients.
|
|
Other: No closure of subcutaneous tissue
in diabetic patients, the subcutaneous fat will not sutured after cesarean section.
|
the subcutaneous fat will not sutured after cesarean section in diabetic patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with surgical site infection
Time Frame: 9 months
|
Surgical site infection: including the following manifestations: Collection; inflammatory signs (pain, tenderness, edema, redness); dehiscence (wound separation) or positive culture.
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with wound seroma
Time Frame: month
|
wound seroma, superficial wound breakdown (defined as skin and/or subcutaneous dehiscence with intact fascial layer).
|
month
|
|
Number of participants with postoperative pain
Time Frame: 24 hours
|
Postoperative pain (judged after 24 hours, through visual analogue scale (VAS); with 0 meaning no pain, and 10 meaning the worst pain).
|
24 hours
|
|
Number of participants with postoperative fever
Time Frame: 48 hours
|
postoperative fever (defined as temperature more than thirty eight degree, 48 hours postoperative.
|
48 hours
|
|
Number of participants with cosmetic wound
Time Frame: 1 month
|
Is cosmetic wound outcome for one month postoperative good or no?
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ceserean section
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Delivery
-
Instituto Materno Infantil Prof. Fernando FigueiraCompletedPyrexia | Abdominal Delivery
-
Insel Gruppe AG, University Hospital BernRecruitingCesarean Section | Delivery, Obstetric | Obstetric DeliverySwitzerland
-
Rambam Health Care CampusRecruitingCesarean Delivery Affecting Fetus | Delivery ComplicationIsrael
-
Alzahraa Ismail Ragheb GodaUnknownDelivery ,Complications,Maternal | Delivery,Complication,FetalEgypt
-
The Reading Hospital and Medical CenterRecruitingPregnancy Related | Cesarean Delivery Affecting Fetus | Delivery ComplicationUnited States
-
Centro di Ricerca Clinica SalentinoRecruitingDelivery Problem | Delivery Complication | Delivery; Injury, Maternal | Delivery; Injury | Delivery Problem for Fetus | Delivery;Breech;StillbirthItaly
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Centre Hospitalier René DubosCompleted
-
University Hospital, CaenCompleted
-
Hadassah Medical OrganizationUnknown
Clinical Trials on closure of subcutaneous tissue
-
The University of The West IndiesNot yet recruiting
-
Rambam Health Care CampusCompletedSuture Line InfectionIsrael
-
Centre Hospitalier Universitaire de NiceCompletedCovid-19 PatientsFrance
-
University of LouisvilleCompleted
-
Medicis Technologies CorporationCompleted
-
St. John Hospital & Medical CenterCompletedSurgical Wound | Tissue AdhesionUnited States
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
-
The University of Texas Health Science Center,...TerminatedEyelid LacerationUnited States
-
Melaka Manipal Medical CollegeCompleted
-
Hospices Civils de LyonCompleted